Significant headache improvement after transsphenoidal surgery in patients with small sellar lesions: Clinical article

Maria Fleseriu, Christine (Chris) Yedinak, Caitlin Campbell, Johnny B. Delashaw

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Object. Pituitary adenomas represent a large proportion of brain tumors that are increasing in incidence because of improved imaging techniques. Headache is the primary symptom in patients with large tumors (macroadenomas), but is also a symptom in patients with small tumors (microadenomas, tumors <1.0 cm). The prevalence and optimal treatment of headaches associated with pituitary tumors is still unclear, particularly in cases of microadenoma. If conventional medical management fails, transsphenoidal surgery (TSS) may be considered as an alternative treatment for intractable headaches. Methods. The authors conducted a retrospective review of 512 patients who underwent TSS at Oregon Health & Science University between 2001 and 2007; patients with Cushing disease were excluded. The authors identified 41 patients with small pituitary tumors who underwent TSS, and retrospectively evaluated the resolution and/or treatment of headache. Results. Ninety percent of patients who presented with nonfunctioning microadenomas and Rathke cleft cysts experienced resolution or improvement in their headaches after TSS, and 56% of patients who presented with hyperfunctioning pituitary microadenomas had improvement in their headaches. There were no postoperative complications. Conclusions. In this retrospective study, the authors demonstrate the efficacy of TSS in the treatment of intractable headaches in patients who present with pituitary microadenomas (nonsecreting and hypersecretory) and Rathke cleft cysts.

Original languageEnglish (US)
Pages (from-to)354-358
Number of pages5
JournalJournal of Neurosurgery
Volume110
Issue number2
DOIs
StatePublished - Feb 2009

Fingerprint

Headache
Pituitary Neoplasms
Central Nervous System Cysts
Headache Disorders
Pituitary ACTH Hypersecretion
Neoplasms
Therapeutics
Brain Neoplasms
Retrospective Studies
Incidence
Health

Keywords

  • Headache
  • Pituitary microadenoma
  • Transsphenoidal surgery

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Significant headache improvement after transsphenoidal surgery in patients with small sellar lesions : Clinical article. / Fleseriu, Maria; Yedinak, Christine (Chris); Campbell, Caitlin; Delashaw, Johnny B.

In: Journal of Neurosurgery, Vol. 110, No. 2, 02.2009, p. 354-358.

Research output: Contribution to journalArticle

@article{26503d9acf014ceba2296ace0b190a6e,
title = "Significant headache improvement after transsphenoidal surgery in patients with small sellar lesions: Clinical article",
abstract = "Object. Pituitary adenomas represent a large proportion of brain tumors that are increasing in incidence because of improved imaging techniques. Headache is the primary symptom in patients with large tumors (macroadenomas), but is also a symptom in patients with small tumors (microadenomas, tumors <1.0 cm). The prevalence and optimal treatment of headaches associated with pituitary tumors is still unclear, particularly in cases of microadenoma. If conventional medical management fails, transsphenoidal surgery (TSS) may be considered as an alternative treatment for intractable headaches. Methods. The authors conducted a retrospective review of 512 patients who underwent TSS at Oregon Health & Science University between 2001 and 2007; patients with Cushing disease were excluded. The authors identified 41 patients with small pituitary tumors who underwent TSS, and retrospectively evaluated the resolution and/or treatment of headache. Results. Ninety percent of patients who presented with nonfunctioning microadenomas and Rathke cleft cysts experienced resolution or improvement in their headaches after TSS, and 56{\%} of patients who presented with hyperfunctioning pituitary microadenomas had improvement in their headaches. There were no postoperative complications. Conclusions. In this retrospective study, the authors demonstrate the efficacy of TSS in the treatment of intractable headaches in patients who present with pituitary microadenomas (nonsecreting and hypersecretory) and Rathke cleft cysts.",
keywords = "Headache, Pituitary microadenoma, Transsphenoidal surgery",
author = "Maria Fleseriu and Yedinak, {Christine (Chris)} and Caitlin Campbell and Delashaw, {Johnny B.}",
year = "2009",
month = "2",
doi = "10.3171/2008.8.JNS08805",
language = "English (US)",
volume = "110",
pages = "354--358",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "2",

}

TY - JOUR

T1 - Significant headache improvement after transsphenoidal surgery in patients with small sellar lesions

T2 - Clinical article

AU - Fleseriu, Maria

AU - Yedinak, Christine (Chris)

AU - Campbell, Caitlin

AU - Delashaw, Johnny B.

PY - 2009/2

Y1 - 2009/2

N2 - Object. Pituitary adenomas represent a large proportion of brain tumors that are increasing in incidence because of improved imaging techniques. Headache is the primary symptom in patients with large tumors (macroadenomas), but is also a symptom in patients with small tumors (microadenomas, tumors <1.0 cm). The prevalence and optimal treatment of headaches associated with pituitary tumors is still unclear, particularly in cases of microadenoma. If conventional medical management fails, transsphenoidal surgery (TSS) may be considered as an alternative treatment for intractable headaches. Methods. The authors conducted a retrospective review of 512 patients who underwent TSS at Oregon Health & Science University between 2001 and 2007; patients with Cushing disease were excluded. The authors identified 41 patients with small pituitary tumors who underwent TSS, and retrospectively evaluated the resolution and/or treatment of headache. Results. Ninety percent of patients who presented with nonfunctioning microadenomas and Rathke cleft cysts experienced resolution or improvement in their headaches after TSS, and 56% of patients who presented with hyperfunctioning pituitary microadenomas had improvement in their headaches. There were no postoperative complications. Conclusions. In this retrospective study, the authors demonstrate the efficacy of TSS in the treatment of intractable headaches in patients who present with pituitary microadenomas (nonsecreting and hypersecretory) and Rathke cleft cysts.

AB - Object. Pituitary adenomas represent a large proportion of brain tumors that are increasing in incidence because of improved imaging techniques. Headache is the primary symptom in patients with large tumors (macroadenomas), but is also a symptom in patients with small tumors (microadenomas, tumors <1.0 cm). The prevalence and optimal treatment of headaches associated with pituitary tumors is still unclear, particularly in cases of microadenoma. If conventional medical management fails, transsphenoidal surgery (TSS) may be considered as an alternative treatment for intractable headaches. Methods. The authors conducted a retrospective review of 512 patients who underwent TSS at Oregon Health & Science University between 2001 and 2007; patients with Cushing disease were excluded. The authors identified 41 patients with small pituitary tumors who underwent TSS, and retrospectively evaluated the resolution and/or treatment of headache. Results. Ninety percent of patients who presented with nonfunctioning microadenomas and Rathke cleft cysts experienced resolution or improvement in their headaches after TSS, and 56% of patients who presented with hyperfunctioning pituitary microadenomas had improvement in their headaches. There were no postoperative complications. Conclusions. In this retrospective study, the authors demonstrate the efficacy of TSS in the treatment of intractable headaches in patients who present with pituitary microadenomas (nonsecreting and hypersecretory) and Rathke cleft cysts.

KW - Headache

KW - Pituitary microadenoma

KW - Transsphenoidal surgery

UR - http://www.scopus.com/inward/record.url?scp=62649095326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62649095326&partnerID=8YFLogxK

U2 - 10.3171/2008.8.JNS08805

DO - 10.3171/2008.8.JNS08805

M3 - Article

C2 - 19012490

AN - SCOPUS:62649095326

VL - 110

SP - 354

EP - 358

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 2

ER -